With the FTC’s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.
presented by
Why Medtronic decided to move now on its $1.1B Intersect ENT deal
Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Google Hangout: Smarter scalpels, safer radiation and scaffolds for sinusitis
The world is changing fast for medical device companies and it’s becoming an evolve or die moment for big companies and small ones. In this month’s MedCity News Google Hangout, I will be talking with four people who working on new and innovative devices. Each person’s work is designed to help patients or make treatment […]
Medtronic-backed Intersect ENT finalizes enrollment for third chronic sinusitus solution
Intersect ENT, a California-based medical devices company with chronic sinusitus drug-delivery solutions, presented a company overview Tuesday at the JP Morgan Healthcare Conference in San Francisco. Chronic sinusitis, which can cause headaches, congestion, facial pain and breathing problems among other issues, affects one of seven adults in the U.S. The company’s tapped this largely unmet clinical need with […]
Value, VCs and international markets: One industry leader’s answers on where medtech fits in
Medtech Women will focus on value in healthcare at its annual Vision conference on Sept. 10 in Menlo Park, Calif. According to the organization’s website, the group brings together medtech’s “business leaders, financial investors, researchers, physicians and experts in new product commercialization.” “A key pillar of the MedtechVision conference is fostering a forum that provokes […]